RB1 and cancer: Stathmin‐mediated disruption of microtubule dynamics is a key factor that induces the combined lethality of RB1‐deficient cancers and suggests that upstream factors that regulate microtubule dynamics, such as AURKA could be potential therapeutic targets for RB1‐deficient cancers.20